1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. BEYONDSPRING INC
BeyondSpring Inc
XNAS: BYSI
Download real time
1.52 0.05 (3.40%)
55.81% Fall from 52W High
3,752.1
XNAS Volume

XNAS 30 Apr, 2026 4:00 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for BeyondSpring Inc

The latest disclosure was made by Lan Huang in BeyondSpring Inc where a trade of 11,514 Stock Options (right to buy) done was reported to US exchanges on April 1, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Lan Huang Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2026 11,514 11,514 - - Stock Options (right to buy)
Brendan Delaney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2026 20,427 20,427 - - Stock Options (right to buy)
Jiangwen Majeti Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2026 21,730 21,730 - - Stock Options (right to buy)
Sihai Xu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2026 18,689 18,689 - - Stock Options (right to buy)
June Lu Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2026 17,840 17,840 - - Stock Options (right to buy)
Patrick Fabbio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2026 22,165 22,165 - - Stock Options (right to buy)
Matthew Kirkby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2026 23,902 23,902 - - Stock Options (right to buy)
Patrick Fabbio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2025 23,793 23,793 - - Stock Options (right to buy)
Lan Huang Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2025 43,630 43,630 - - Stock Options (right to buy)
Matthew Kirkby Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2025 25,763 25,763 - - Stock Options (right to buy)
Brendan Delaney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2025 21,822 21,822 - - Stock Options (right to buy)
Jiangwen Majeti Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2025 23,300 23,300 - - Stock Options (right to buy)
Sihai Xu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2025 19,852 19,852 - - Stock Options (right to buy)
June Lu Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Apr 2025 18,981 18,981 - - Stock Options (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters